Any feedback?
Literature summary for 3.4.21.117 extracted from
- Expression of kallikrein 7 diminishes pancreatic cancer cell adhesion to vitronectin and enhances urokinase-type plasminogen activator receptor shedding (2008), Pancreas, 37, 399-404.
Application
| Application | Comment | Organism |
|---|---|---|
| medicine | ectopic expression of KLK7 in pancreatic cancer cells leads to a reduction in cell adhesion to vitronectin that may result from the cleavage of uPAR from the cell surface. KLK 7 expression, plays an important role in the dissemination of tumor cells through the production of soluble uPAR in pancreatic cancer | Homo sapiens |
Protein Variants
| Protein Variants | Comment | Organism |
|---|---|---|
| additional information | KLK7 is overexpressed in the pancreatic cancer cell line BxPC-3, and in vitro cell adhesion assays are performed to determine alterations in cell adhesion to collagen I, fibronectin, and vitronectin compared with vector-transfected cells. Changes in cell surface expression of alphavbeta3 integrin are examined by flow cytometry, and the release of soluble urokinase-type plasminogen activator receptor (uPAR) is monitored by Western blot analysis. The expression of KLK7 in BxPC-3 cells leads to reduced adhesion to vitronectin but not collagen I or fibronectin. Loss of cell adhesion to vitronectin is not caused by changes in the level of alphavbeta3 integrin cell surface expression. A significant increase in the amount of uPAR shed is observed in KLK7-expressing cells compared with vector-transfected control cells | Homo sapiens |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | - |
- |
- |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| kallikrein 7 | - |
Homo sapiens |
| KLK7 | - |
Homo sapiens |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
